United Pharm (033270) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.051x

Based on the latest financial reports, United Pharm (033270) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩23.01 Billion ≈ $15.59 Million USD) by net assets (₩454.63 Billion ≈ $308.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

United Pharm - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how United Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read United Pharm (033270) total liabilities for a breakdown of total debt and financial obligations.

United Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of United Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quang Viet Enterprise Co Ltd TW:4438	-0.025x
SNS KLSE:0259	-0.411x
Ceragon Networks Ltd NASDAQ:CRNT	0.069x
Samyoung Elec KO:005680	0.016x
Catella AB (publ) ST:CAT-B	0.009x
i-SENS Inc KQ:099190	0.018x
Atomera Inc NASDAQ:ATOM	-0.175x
Aurora Cannabis Inc NASDAQ:ACB	0.030x

Annual Cash Flow Conversion Efficiency for United Pharm (2011–2025)

The table below shows the annual cash flow conversion efficiency of United Pharm from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see United Pharm (033270) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩454.63 Billion ≈ $308.10 Million	₩51.14 Billion ≈ $34.65 Million	0.112x	+70.52%
2024-12-31	₩406.21 Billion ≈ $275.28 Million	₩26.79 Billion ≈ $18.16 Million	0.066x	-49.81%
2023-12-31	₩378.68 Billion ≈ $256.63 Million	₩49.77 Billion ≈ $33.73 Million	0.131x	-30.38%
2022-12-31	₩337.86 Billion ≈ $228.96 Million	₩63.78 Billion ≈ $43.22 Million	0.189x	+28.77%
2021-12-31	₩300.71 Billion ≈ $203.79 Million	₩44.09 Billion ≈ $29.88 Million	0.147x	+9.82%
2020-12-31	₩276.89 Billion ≈ $187.65 Million	₩36.96 Billion ≈ $25.05 Million	0.133x	-10.75%
2019-12-31	₩255.10 Billion ≈ $172.88 Million	₩38.15 Billion ≈ $25.86 Million	0.150x	-7.30%
2018-12-31	₩228.48 Billion ≈ $154.84 Million	₩36.86 Billion ≈ $24.98 Million	0.161x	+17.54%
2017-12-31	₩201.68 Billion ≈ $136.68 Million	₩27.68 Billion ≈ $18.76 Million	0.137x	-18.90%
2016-12-31	₩177.39 Billion ≈ $120.21 Million	₩30.02 Billion ≈ $20.34 Million	0.169x	+28.50%
2014-12-31	₩161.83 Billion ≈ $109.67 Million	₩21.31 Billion ≈ $14.44 Million	0.132x	-1.80%
2013-12-31	₩141.44 Billion ≈ $95.85 Million	₩18.97 Billion ≈ $12.85 Million	0.134x	-18.19%
2012-12-31	₩133.48 Billion ≈ $90.46 Million	₩21.88 Billion ≈ $14.83 Million	0.164x	-32.90%
2011-12-31	₩113.04 Billion ≈ $76.61 Million	₩27.62 Billion ≈ $18.72 Million	0.244x	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$197.70 Million

₩291.72 Billion KRW

Market Cap Rank

#16575 Global

#704 in Korea

Share Price

₩20200.00

Change (1 day)

-1.70%

52-Week Range

₩18130.00 - ₩22350.00

All Time High

₩95918.11